Simultaneous characterization of metabolic, cardiac, vascular and renal phenotypes of lean and obese SHHF rats

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Youcef, Gina ^a,b,c,d   Olivier, Arnaud ^a,b,c,e,f   L'Huillier, Clément P J ^a,b,c   Labat, Carlos ^a,b,c   Fay, Renaud ^e,f   Tabcheh, Lina ^b,c,g   Toupance, Simon ^a,b,c,e,f   Rodriguez Guéant, Rosa Maria ^b,c,e,h   Bergerot, Damien ⁱ   Jaisser, Frédéric ^e,f   Lacolley, Patrick ^a,b,c,e   Zannad, Faiez ^a,b,c,e,f   Vallar, Laurent ^d   Pizard, Anne ^a,b,c,f  

^a INSERM UMR S 1116 University of Lorraine   (France)

^b Fédération de Recherche 3209   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f CIC 1433   (France)

^g Biopôle de l Université de Lorraine   (France)

^h INSERM   (France)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; GENE MUTATION; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HISTOLOGY; HYPERTENSION; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PHENOTYPE; POLYURIA; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SYSTOLIC DYSFUNCTION; ANIMAL; BLOOD PRESSURE; DISEASE COURSE; DISEASE MODEL; ECHOCARDIOGRAPHY; HEMODYNAMICS; INSULIN RESISTANCE; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; SYSTOLE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; HEART FAILURE; HEMODYNAMICS; HYPERTENSION; INSULIN RESISTANCE; KIDNEY; MALE; METABOLIC SYNDROME X; PHENOTYPE; RATS; SYSTOLE;

EID: 84901359662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096452     Document Type: Article

References (37)

1. Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O'Connor CM (2013) Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail.
2. Aroor AR, Madavia CH, Sowers JR (2012) Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin 8: 609-617.
3. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8: 30-41.
4. De Pergola G, Nardecchia A, Giagulli VA, Triggiani V, Guastamacchia E, et al. (2013) Obesity and Heart Failure. Endocr Metab Immune Disord Drug Targets.
5. Ebong IA, Goff DC Jr, Rodriguez CJ, Chen H, Bluemke DA, et al. (2013) The relationship between measures of obesity and incident heart failure: The multi-ethnic study of atherosclerosis. Obesity (Silver Spring).
6. Bountiouskos M, Schinkel A, BAx J, Lampropoulos S, Poldermans D (2006) The impact of hypertension on systolic and diastolic left ventricular function. A tissue Doppler echocardiographic study. American Heart Journal 151.
7. Ingelsson E, Arnlov J, Sundstrom J, Zethelius B, Vessby B, et al. (2005) Novel metabolic risk factors for heart failure. J Am Coll Cardiol 46: 2054-2060.
8. Aspelund T, Gudnason V, Magnusdottir BT, Andersen K, Sigurdsson G, et al. (2010) Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One 5: e13957.
9. Horwich TB, Fonarow GC (2010) Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol 55: 283-293.
10. Simpson CR, Buckley BS, McLernon DJ, Sheikh A, Murphy A, et al. (2011) Five-year prognosis in an incident cohort of people presenting with acute myocardial infarction. PLoS One 6: e26573.
11. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, et al. (2012) Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail 14: 120-129.
12. Altschuld RA, Holycross BJ, Radin MJ, McCune SA (2003) The failing SHHF Rat heart. Cardiac remodeling and failure: 67-75.
13. McCune SA, Baker PB, Stills Jr HF (1990) SHHF/Mcc-cp Rat: Model of obesity, Non-insulin-dependant Diabetes, and Congestive Heart Failure. ILAR News 32: 23-27.
14. Greenhouse DD, Michaelis IV OE, McCune SA (1990) Development of corpulent rat strains. Frontiers in diabetes research Lessons from animal diabetes III VIII: 375-377.
15. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, et al. (2002) Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283: H1775-1784. (Pubitemid 35217010)
16. Hoversland RC (1992) Onset of obesity and puberty in genetically obese SHHF/Mcc-cp rats. Int J Obes Relat Metab Disord 16: 977-984.
17. McCune SA, Jenkins JE, Stills Jr HJ, Park S, Radin MJ, et al. (1990) Renal and heart functions in the SHHF/Mcc-cp rat. Frontiers in diabetes research Lessons from animal diabetes III VIII.6.: 397-401.
18. McCune SA, Radin MJ, Jenkins JE, CHU Y-Y, Park S, et al. (1995) SHHF/Mcc-facp rat model: effects of gender and genotype on age of expression of metabolic complications and congestive heart failure and on response to drug therapy. Leesons from animal diabetes: 255-270.
19. Meier DA, Hennes MM, McCune SA, Kissebah AH (1995) Effects of obesity and gender on insulin receptor expression in liver of SHHF/Mcc-FAcp rats. Obes Res 3: 465-470.
20. Haas GJ, McCune SA, Brown DM, Cody RJ (1995) Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. Am Heart J 130: 806-811.
21. Reffelmann T, Kloner RA (2003) Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol 98: 275-284. (Pubitemid 37107654)
22. Radin MJ, Jenkins JE, McCune SA, Jurin RR, Hamlin RL (1992) Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats. J Cardiovasc Pharmacol 19: 464-472.
23. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, et al. (2002) Increased carotid wall elastic modulus and fibronectin in aldosterone-salt- treated rats: effects of eplerenone. Circulation 106: 2848-2853. (Pubitemid 35396986)
24. Fellmann L, Nascimento AR, Tibirica E, Bousquet P (2012) Murine models for pharmacological studies of the metabolic syndrome. Pharmacol Ther 137: 331-340.
25. Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, et al. (2011) Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology 152: 113-125.
26. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, et al. (2007) Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21: 2185-2194. (Pubitemid 47026453)
27. Kim SH, Chu YK, Kwon OW, McCune SA, Davidorf FH (1998) Morphologic studies of the retina in a new diabetic model; SHR/N:Mcc-cp rat. Yonsei Med J 39: 453-462. (Pubitemid 128506906)
28. Friedman JE, Ferrara CM, Aulak KS, Hatzoglou M, McCune SA, et al. (1997) Exercise training down-regulates ob gene expression in the genetically obese SHHF/Mcc-fa(cp) rat. Horm Metab Res 29: 214-219. (Pubitemid 27287898)
29. Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, et al. (2002) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15: 1101-1108. (Pubitemid 35397546)
30. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, et al. (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60: 1455-1469.
31. Sloboda N, Feve B, Thornton SN, Nzietchueng R, Regnault V, et al. (2012) Fatty acids impair endothelium-dependent vasorelaxation: a link between obesity and arterial stiffness in very old Zucker rats. J Gerontol A Biol Sci Med Sci 67: 927-938.
32. Masson S, Gori F, Latini R, Milani V, Flyvbjerg A, et al (2011) Adiponectin in chronic heart failure: influence of diabetes and genetic variants. Eur J Clin Invest. 41: 1330-8.
33. Van Berendoncks AM, Conraads VM (2011) Functional adiponectin resistance and exercise intolerance in heart failure. Curr Heart Fail Rep. 8: 113-22.
34. Holycross BJ, Summers BM, Dunn RB, McCune SA (1997) Plasma renin activity in heart failure-prone SHHF/Mcc-facp rats. Am J Physiol 273: H228-233.
35. Przybylski R, McCune S, Hollis B, Simpson RU (2010) Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis 20: 641-646.
36. Radin MJ, Holycross BJ, Hoepf TM, McCune SA (2003) Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem 242: 57-63. (Pubitemid 36240529)
37. Griffin KA, Abu-Naser M, Abu-Amarah I, Picken M, Williamson GA, et al. (2007) Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes. Am J Physiol Renal Physiol 293: F1605-1613.